監管
Moderna receives FDA approval for updated 2026-2027 COVID-19 vaccines
Moderna said the U.S. FDA approved its updated 2026-2027 formula COVID-19 vaccines, clearing the company's product for the coming respiratory season.
文章預覽
This is a paid press release. Contact the press release distributor directly with any inquiries. Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines · ACCESS Newswire · Moderna, Inc. Moderna, Inc. Fri, August 28, 2026 at 5:56 AM GMT+10 7 min read MRNA CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2026-2027 formulas for Spikev…